Forma Therapeutics Holdings Overview

Forma Therapeutics Holdings Selling, General & Admin

Selling, General & Admin expenses for FMTX.

Quarterly SG&A Expenses

$13.94M

↑ 11.77% YoY

As of Jun 30, 2022

Annual SG&A Expenses (TTM)

$53.06M

↑ 40.6% YoY

Trailing 12 months ending Jun 30, 2022

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin